Gilbert & Cook, Inc. Bristol Myers Squibb CO Transaction History

Gilbert & Cook, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $41,857 - $46,476	657 Added 6.77%	10,355 $662,000
Q1 2023 May 05, 2023	BUY	$65.71 - $74.53 $6,833 - $7,751	104 Added 1.08%	9,698 $672,000
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $9,039 - $10,703	132 Added 1.4%	9,594 $690,000
Q3 2022 Nov 03, 2022	BUY	$0.13 - $76.84 $20 - $12,294	160 Added 1.72%	9,462 $733,000
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $30,790 - $33,911	-424 Reduced 4.36%	9,302 $716,000
Q1 2022 May 02, 2022	BUY	$61.48 - $73.72 $59,758 - $71,655	972 Added 11.1%	9,726 $710,000
Q4 2021 Jan 19, 2022	BUY	$53.63 - $62.52 $53,147 - $61,957	991 Added 12.77%	8,754 $546,000
Q3 2021 Jan 20, 2022	BUY	$59.17 - $69.31 $398,628 - $466,941	6,737 Added 656.63%	7,763 $459,000
Q3 2021 Oct 13, 2021	SELL	$59.17 - $69.31 $224,964 - $263,516	-3,802 Reduced 78.75%	1,026 $459,000
Q2 2021 Jul 13, 2021	BUY	$61.91 - $67.42 $5,819 - $6,337	94 Added 1.99%	4,828 $323,000
Q1 2021 Apr 14, 2021	BUY	$59.34 - $66.74 $51,685 - $58,130	871 Added 22.55%	4,734 $299,000
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $31,006 - $35,135	537 Added 16.15%	3,863 $241,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $191,012 - $211,666	3,326 New	3,326 $201,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Gilbert & Cook, Inc., based on Form 13F filings with the SEC.

Stay updated on Gilbert & Cook, Inc. with notifications on news.